1 of 1
Story summary
- At a U.N. drugs meeting in Vienna on March 9, 2023, the United States and China exchanged accusations regarding the fentanyl trade.
- The U.S. accused China of not controlling precursor chemical sales, while China labeled the claims as false and criticized the U.S. as irresponsible.
- Sara Carter, director of the White House Office of National Drug Control Policy, stated that China's lax export controls enable drug cartels.
- A previous agreement between President Trump and President Xi Jinping involved the U.S. reducing tariffs in exchange for China's action against fentanyl.
- Recently, the U.S. Supreme Court invalidated a 10% fentanyl-related tariff.
